Publication | Closed Access
Safety and Efficacy of Ziv-Aflibercept in the Treatment of Refractory Diabetic Macular Edema
17
Citations
15
References
2017
Year
Ziv-aflibercept appears to be safe and effective in patients with refractory DME previously treated with other anti-VEGF agents in the short term. [Ophthalmic Surg Lasers Imaging Retina. 2017;48:399-405.].
| Year | Citations | |
|---|---|---|
Page 1
Page 1